Literature DB >> 12354867

Evaluation of a cytomegalovirus glycoprotein B recombinant enzyme immunoassay to discriminate between a recent and a past infection.

M J Sipewa1, P Goubau, M Bodéus.   

Abstract

Fetal damage following cytomegalovirus (CMV) intrauterine infection is mostly linked to primary infection. To differentiate primary infection from nonprimary infection, immunoglobulin M (IgM) tests are not reliable enough, and measurement of the IgG avidity appears to be the method that is the most widely used at present. In the present study the performance of the Vidas (bioMérieux) avidity assay was compared with that of a new enzyme immunoassay based on the use of a recombinant CMV glycoprotein B protein (Biotest).

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12354867      PMCID： PMC130869          DOI： 10.1128/JCM.40.10.3689-3693.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  Ability of three IgG-avidity assays to exclude recent cytomegalovirus infection.

Authors:  M Bodéus; D Beulné; P Goubau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-04       Impact factor: 3.267

2.  Combination of microneutralization and avidity assays: improved diagnosis of recent primary human cytomegalovirus infection in single serum sample of second trimester pregnancy.

Authors:  M Eggers; U Bäder; G Enders
Journal:  J Med Virol       Date:  2000-03       Impact factor: 2.327

3.  A novel Western blot test containing both viral and recombinant proteins for anticytomegalovirus immunoglobulin M detection.

Authors:  T Lazzarotto; G T Maine; P Dal Monte; A Ripalti; M P Landini
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

4.  Detection of serum immunoglobulin M to human cytomegalovirus by western blotting correlates better with virological data than detection by conventional enzyme immunoassay.

Authors:  T Lazzarotto; G T Maine; P Del Monte; H Frush; K Shi; M P Landini
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

5.  Evaluation of virological procedures to detect fetal human cytomegalovirus infection: avidity of IgG antibodies, virus detection in amniotic fluid and maternal serum.

Authors:  G Ruellan-Eugene; P Barjot; M Campet; A Vabret; M Herlicoviez; G Muller; G Levy; B Guillois; F Freymuth
Journal:  J Med Virol       Date:  1996-09       Impact factor: 2.327

6.  Antibody response to cytomegalovirus after renal transplantation: comparison of patients with primary and recurrent infections.

Authors:  R F Pass; P D Griffiths; A M August
Journal:  J Infect Dis       Date:  1983-01       Impact factor: 5.226

7.  Role of polyclonal activation in specific immune responses. Relevance for findings of antibody activity in various diseases.

Authors:  E Möller; H Ström; S Al-Balaghi
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

8.  Predictive value of maternal-IgG avidity for congenital human cytomegalovirus infection.

Authors:  M Bodéus; P Goubau
Journal:  J Clin Virol       Date:  1999-01       Impact factor: 3.168

9.  Specific IgM class antibody production following infection with cytomegalovirus.

Authors:  H O Kangro; P D Griffiths; T J Huber; R B Heath
Journal:  J Med Virol       Date:  1982       Impact factor: 2.327

10.  Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection.

Authors:  S Stagno; R F Pass; M E Dworsky; R E Henderson; E G Moore; P D Walton; C A Alford
Journal:  N Engl J Med       Date:  1982-04-22       Impact factor: 91.245
View more
  1 in total

1.  Distinguishing primary CMV infection from reactivation of latent infection.

Authors:  Venkataraman Subramanian
Journal:  Dig Dis Sci       Date:  2007-05-09       Impact factor: 3.199
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.